Department of Hepatobiliary Sciences and Liver Transplantation, Division of Hepatology, King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia.
Saudi J Gastroenterol. 2012 Sep-Oct;18(5):334-8. doi: 10.4103/1319-3767.101135.
BACKGROUND/AIM: To evaluate the clinical manifestations, diagnostic features, disease course and response to treatment among Saudi adults with predominantly hepatic Wilson's disease. A retrospective cohort study of 40 adult patients diagnosed with predominantly hepatic Wilson's disease between 1994 and 2008 at King Abdulaziz Medical City, Riyadh was carried out.
The diagnosis was based on varying combinations of clinical and laboratory evidence of liver disease, presence of Kayser Fleisher rings, low serum ceruloplasmin levels, elevated 24 hour urinary copper excretion and histopathological findings on liver biopsy.
The most frequent clinical presentation was decompensated chronic liver disease in 19 (47.5%), followed by chronic hepatitis in 15 (37.5%) and fulminant hepatic failure (FHF) in 5 (12.5%) patients. Eight (20%) patients with end-stage liver disease had liver transplantation, while 24 (60%) patients followed up on medical treatment for a variable period of 1-12 years showed clinical and laboratory improvement. One patient was lost early in follow up. Eight (20%) patients died during the study period, 5 with FHF, and 2 with advanced hepatic and neurological disease and one seven years after liver transplantation. Mortality rate was 100% in FHF without liver transplantation.
A predominantly hepatic Wilson's disease has varied clinical presentations with decompensated chronic liver disease being the most common among adult patients. Majority of the patients show stabilization of the disease on medical treatment. FHF in Wilson's disease has a grave prognosis without liver transplantation, the later remains a definitive treatment option for decompensated cirrhotics and patients with FHF.
背景/目的:评估主要表现为肝型威尔逊病的沙特成年患者的临床表现、诊断特征、疾病过程和治疗反应。对 1994 年至 2008 年期间在利雅得阿卜杜勒阿齐兹国王医疗城被诊断为主要表现为肝型威尔逊病的 40 例成年患者进行回顾性队列研究。
诊断基于肝脏疾病的临床和实验室证据、凯氏环的存在、血清铜蓝蛋白水平降低、24 小时尿铜排泄量升高和肝活检的组织病理学发现等不同组合。
最常见的临床表现为失代偿性慢性肝病 19 例(47.5%),其次为慢性肝炎 15 例(37.5%)和暴发性肝衰竭(FHF)5 例(12.5%)。8 例(20%)终末期肝病患者接受了肝移植,而 24 例(60%)接受了不同时间的药物治疗(1-12 年)的患者显示出临床和实验室改善。1 例患者在随访早期丢失。在研究期间,有 8 例(20%)患者死亡,其中 5 例死于 FHF,2 例死于晚期肝和神经疾病,1 例死于肝移植后 7 年。未进行肝移植的 FHF 患者死亡率为 100%。
主要表现为肝型威尔逊病的临床表现多种多样,失代偿性慢性肝病在成年患者中最为常见。大多数患者在接受药物治疗后病情稳定。未进行肝移植的威尔逊病 FHF 预后严重,肝移植仍是失代偿性肝硬化和 FHF 患者的明确治疗选择。